Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP
Suzanne E. Schindler, MD, PhD
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Charles Turck, PharmD, BCPS, BCCCP
Jasmohan Bajaj, MD
ADHD in Older Adults: Key Diagnostic and Treatment Strategies
David Goodman, MD, LFAPA
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
Jagan Pillai, MD, PhD
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Andrew Wilner, MD, FACP, FAAN
Marcus E. Peter, PhD
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
George Bloom, PhD
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Marc Haut, PhD
A Look at Lecanemab: The Latest Breakthrough in Alzheimer’s Treatment
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
David Weisman, MD
Investigating the Link Between Hypertension Medications & Dementia
Zachary Marcum, PharmD, PhD
Alzheimer’s Disease: What’s The Latest Research?
Jerome Lisk, MD, MBA, M.S., FAAN
Peter Whitehouse, MD, PhD
Daniel George, MSc, PhD
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
Olive Oil: The Secret Ingredient Preventing Alzheimer's Disease?
Brian P. McDonough, MD, FAAFP
Can Mentally Stimulating Activities Reduce the Risk of Mild Cognitive Impairment in Seniors?
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.